|
Market Closed -
London S.E.
10:05:01 06/11/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 77.50 GBX | 0.00% |
|
-6.06% | -3.73% |
| 15/10 | Arecor Therapeutics Obtains Patents in Europe, US, India, for Rapid-acting Insulin | MT |
| 15/10 | Arecor Therapeutics Plc Strengthens Patent Protection For Its Proprietary AT278 Product | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ARECOR THERAPEUTICS PLC | Other Biotechnology & Medical Research | 0.00% | -6.06% | -3.73% | +6.90% | -81.10% | 4.73Cr |
-
|
-
|
-
|
- Stock Market
- Stocks
- AREC Stock
- Charts Arecor Therapeutics plc
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
